CClinicalTrials.gg
CompletedNCT01893593Updated Aug 15, 2014

Young Hearts, Strong Starts

A Phase 4 interventional study of Intervention and Control in Cardiovascular Risk Reduction, sponsored by RTI International. Completed at 2 sites in United States. Open to participants aged 3 Years to 11 Years. Per ClinicalTrials.gov, last updated 2014-08-15.

Sponsored by RTI International · Phase 4, Interventional, and Prevention

Phase
Phase 4
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
3 Years to 11 Years
Sex
All
01

Study summary

This is a cluster randomized trial of pediatric cardiovascular risk reduction guideline implementation in 32 clinical practices

Read the detailed description

Objective: The Young Hearts Strong Starts Study was designed to test strategies to facilitate adoption of the Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents among pediatric and family medicine providers. The study compares quality measures based on the guidelines for two dissemination strategies: a multi-faceted, practice-directed intervention or standard dissemination.

Methods: Two primary care research networks recruited practices and provided support for the intervention and outcome evaluations. Individual practices were randomly assigned to either the intervention or control groups using a cluster randomized design based on network affiliation, number of clinicians per practice, urban vs. nonurban location, and practice type. In this design, the units of observation are individual children because outcomes are abstracted from medical records for individual patients. The units of randomization are physician practices. This results in a multilevel design in which patients are nested within practices. Implementation The intervention practices receive toolkits, including guideline summaries and slides, a patient and family behavior change workbook, and a clinical decision support tool. Guideline implementation was promoted through an introductory academic detailing session and the use of an ongoing e-learning group. The intervention strategy was further enhanced by aligning this project with the American Board of Pediatrics quality improvement Maintenance of Certification (MOC) requirements and offers voluntary MOC participation to participants. MOC participation includes the creation of a practice aims statement, monthly physician self-abstraction to track progress throughout the intervention, and participation in webinar presentations and sharing of best practices.

02

Conditions studied

  • Cardiovascular Risk Reduction

Keywords

  • Cardiovascular risk
  • lifestyle change
  • blood pressure
  • body mass index
  • tobacco
03

In context

Lead sponsor

RTI International is the lead sponsor of 81 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients seen for well child visits

Exclusion criteria

Exclusion Criteria:

  • Terminally ill patients
05

Study design

Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Other
    Control

    Usual care

    Other: Control

  • Active comparator
    Intervention

    Multifaceted intervention to improve clinical systems

    Other: Intervention

Interventions

  • OtherIntervention

    Guideline summary and data feedback from a baseline medical record review and a multifaceted intervention to improve clinical systems

  • OtherControl

    Guideline summary and data feedback from a baseline medical record review

06

What researchers measure

Primary outcomes

  1. Summary composite measure of practice performance and exposure

    Summary measures of the number of guideline recommended actions in each area divided by the number of eligible patients. Process measures of adherence to guidelines in the measurement, interpretation, and recommendations for blood pressue and BMI, and measures of assessment and advice for tobacco exposure and use.

    Time frame: One year

Secondary outcomes

  1. Measures of guideline adherence for BMI, blood pressure, and tobacco use and exposure

    Process measures of adherence to guidelines in the measurement, interpretation, and recommendations for blood pressue and BMI, and measures of assessment and advice for tobacco exposure and use.

    Time frame: One year

07

Study locations

2 sites
  • Lurie Children's Hospital
    Chicago, Illinois 60611, United States
  • East Carolina University
    Greenville, North Carolina 27858, United States
08

References and documents

Publications

  • LaBresh KA, Ariza AJ, Lazorick S, Furberg RD, Whetstone L, Hobbs C, de Jesus J, Salinas IG, Bender RH, Binns HJ. Adoption of cardiovascular risk reduction guidelines: a cluster-randomized trial. Pediatrics. 2014 Sep;134(3):e732-8. doi: 10.1542/peds.2014-0876. PubMed 25157013 ↗
  • LaBresh KA, Lazorick S, Ariza AJ, Furberg RD, Whetstone L, Hobbs C, de Jesus J, Bender RH, Salinas IG, Binns HJ. Implementation of the NHLBI integrated guidelines for cardiovascular health and risk reduction in children and adolescents: rationale and study design for young hearts, strong starts, a cluster-randomized trial targeting body mass index, blood pressure, and tobacco. Contemp Clin Trials. 2014 Jan;37(1):98-105. doi: 10.1016/j.cct.2013.11.011. Epub 2013 Dec 1. PubMed 24295879 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01893593
Lead sponsor
RTI International
Collaborators
East Carolina University, Pediatric Practice Research Group, Ann & Robert H Lurie Children's Hospital of Chicago
Responsible party
Sponsor
First posted
Jul 9, 2013
Start date
Nov 2011
Primary completion
Dec 2012
Completion
Oct 2013
Last update
Aug 15, 2014

Study contacts

Ken LaBresh, MD
principal investigator · RTI International

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion